NCT02151877 - Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 15, 2018

Study Completion Date

August 15, 2018

Conditions

Ischemia/Reperfusion Injury After Neonatal Cardiac SurgeryInflammatory Reaction After Neonatal Cardiac Surgery

Interventions

DRUG

Inhaled Nitric Oxide

delivering inhaled Nitric Oxide into the cardiopulmonary bypass circuit during neonatal cardiac surgery

DRUG

placebo

inhaled Nitric Oxide not delivered to the cardiopulmonary bypass circuit during neonatal cardiac surgery

Trial Locations (1)

Advocate Children's Hospital, Oak Lawn